Insider Trading activities of Regeneron Pharmaceuticals Inc insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Regeneron Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Regeneron Pharmaceuticals Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Regeneron Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is REGN. The reporting company's CIK number is 872589.
The total value of stock buying since 2005 is $2,475,753,844.
The total value of stock sales since 2005 is $1,068,888,188.
The total value of stock option exercises since 2005 is $284,711,527.



Table 2. Detailed insider stock purchases, sales, and option exercises of Regeneron Pharmaceuticals Inc insiders (REGN) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-08-31 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 5,296 145.94 772,914
2012-08-29 Stahl Neil (SVP Research and Development S) Sale 16,884 145.59 2,458,141
2012-08-28 Stahl Neil (SVP Research and Development S) Option Ex 40,000 21.92 876,800
2012-08-24 Mccorkle Douglas S (VP Controller and Asst Treasur) Sale 6,727 144.67 973,181
2012-08-23 Mccorkle Douglas S (VP Controller and Asst Treasur) Option Ex 15,125 25.94 392,342
2012-08-23 Roberts William (VP Regulatory Development and) Sale 15,000 144.00 2,160,000
2012-08-23 Sing George L (Director) Sale 5,000 142.00 710,000
2012-08-23 Sing George L (Director) Option Ex 5,000 18.80 94,000
2012-08-22 Sing George L (Director) Sale 5,000 139.00 695,000
2012-08-22 Sing George L (Director) Option Ex 5,000 18.80 94,000
2012-08-10 Ryan Arthur F (Director) Sale 10,000 136.15 1,361,500
2012-08-07 Gilman Alfred G (Director) Sale 15,000 139.56 2,093,400
2012-08-07 Gilman Alfred G (Director) Option Ex 15,000 15.80 237,000
2012-08-06 Brown Michael S (Director) Sale 3,000 136.29 408,870
2012-08-06 Brown Michael S (Director) Option Ex 3,000 23.84 71,520
2012-08-01 Powchik Peter (SVP Clinical Development & Reg) Option Ex 14,990 18.78 281,512
2012-07-30 Terifay Robert J (SVP Commercial) Sale 23,834 136.08 3,243,330
2012-07-27 Terifay Robert J (SVP Commercial) Option Ex 50,875 18.51 941,543
2012-07-26 Powchik Peter (SVP Clinical Development & Reg) Sale 7,019 130.74 917,628
2012-07-26 Sing George L (Director) Sale 5,000 135.00 675,000
2012-07-26 Sing George L (Director) Option Ex 5,000 18.80 94,000
2012-07-25 Powchik Peter (SVP Clinical Development & Reg) Option Ex 15,000 16.80 252,000
2012-06-19 Stahl Neil (SVP Res & Dev Sciences) Sale 38,911 116.86 4,547,256
2012-06-18 Stahl Neil (SVP Res & Dev Sciences) Option Ex 95,079 20.32 1,932,005
2012-05-31 Sing George L (Director) Sale 5,000 134.94 674,725
2012-05-30 Sing George L (Director) Sale 5,000 134.00 670,000
2012-05-24 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 500 24.00 12,000
2012-05-21 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 16,244 16.78 272,574
2012-05-21 Shooter Eric M (Director) Sale 18,000 123.65 2,225,700
2012-05-21 Shooter Eric M (Director) Option Ex 18,000 21.51 387,180
2012-05-18 Shooter Eric M (Director) Sale 2,000 124.04 248,080
2012-05-18 Shooter Eric M (Director) Option Ex 2,000 18.61 37,220
2012-05-03 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 24,642 135.51 3,339,163
2012-05-02 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 6,945 136.48 947,853
2012-05-02 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 54,438 21.92 1,193,280
2012-05-01 Aberman Michael S (VP Strategy and Investor Relat) Sale 6,162 134.91 831,284
2012-05-01 Yancopoulos George (EVP CSO President Regeneron Re) Sale 33,165 134.59 4,463,776
2012-05-01 Schleifer Leonard S (President & CEO) Sale 100,000 135.07 13,506,800
2012-04-30 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 12,500 24.00 300,000
2012-04-30 Van Plew Daniel P (SVP & General Mgr Industrial O) Sale 14,442 136.18 1,966,711
2012-04-27 Van Plew Daniel P (SVP & General Mgr Industrial O) Option Ex 35,216 20.90 736,014
2012-04-19 Baker Charles A (Director) Sale 12,910 125.00 1,613,750
2012-04-19 Baker Charles A (Director) Option Ex 12,910 18.80 242,708
2012-04-17 Baker Charles A (Director) Sale 2,090 125.00 261,250
2012-04-17 Baker Charles A (Director) Option Ex 2,090 18.80 39,292
2012-03-26 Yancopoulos George (EVP CSO President Regeneron Re) Sale 33,150 120.65 3,999,547
2012-03-26 Goldstein Joseph L (Director) Sale 5,000 120.00 600,000
2012-03-26 Goldstein Joseph L (Director) Option Ex 5,000 18.61 93,050
2012-03-15 Goldstein Joseph L (Director) Sale 10,000 112.28 1,122,770
2012-03-15 Goldstein Joseph L (Director) Option Ex 10,000 18.61 186,100
2012-03-01 Brown Michael S (Director) Sale 20,000 103.29 2,065,720
2012-03-01 Brown Michael S (Director) Option Ex 20,000 18.91 378,240
2012-02-23 Shooter Eric M (Director) Sale 20,000 103.78 2,075,600
2012-02-22 Powchik Peter (SVP Clinical Development & Reg) Sale 49,254 96.45 4,750,548
2012-02-21 Powchik Peter (SVP Clinical Development & Reg) Option Ex 109,866 18.67 2,051,198
2012-02-16 Mccorkle Douglas S (VP Controller and Asst Treasur) Sale 5,353 107.50 575,447
2012-02-15 Mccorkle Douglas S (VP Controller and Asst Treasur) Sale 9,097 111.08 1,010,494
2012-02-15 Yancopoulos George (EVP CSO President Regeneron Re) Option Ex 133,332 8.50 1,133,322
2012-02-15 Stahl Neil (SVP Research and Development S) Sale 21,082 107.94 2,275,591
2012-02-15 Gilman Alfred G (Director) Sale 26,734 109.56 2,928,977
2012-02-14 Mccorkle Douglas S (VP Controller and Asst Treasur) Sale 4,562 109.75 500,702
2012-02-14 Mccorkle Douglas S (VP Controller and Asst Treasur) Option Ex 35,000 20.64 722,400
2012-02-14 Stahl Neil (SVP Research and Development S) Sale 31,202 110.55 3,449,474
2012-02-14 Stahl Neil (SVP Research and Development S) Option Ex 50,000 16.80 840,000
2012-02-14 Goldstein Joseph L (Director) Sale 15,000 110.02 1,650,300
2012-02-14 Goldstein Joseph L (Director) Option Ex 15,000 28.91 433,725
2012-02-14 Gilman Alfred G (Director) Option Ex 30,000 12.09 362,700
2012-02-14 Schleifer Leonard S (President & CEO) Option Ex 500,000 15.14 7,571,500
2012-02-13 Stahl Neil (SVP Research and Development S) Option Ex 66,666 8.50 566,661
2012-02-07 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 17,500 100.48 1,758,400
2012-02-06 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 40,913 20.97 857,945
2012-02-01 Terifay Robert J (SVP Commercial) Sale 9,439 90.79 856,966
2012-02-01 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 18,258 91.90 1,677,964
2012-01-31 Terifay Robert J (SVP Commercial) Option Ex 23,128 21.92 506,965
2012-01-31 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 44,079 21.12 930,948
2012-01-20 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 17,183 78.51 1,349,088
2012-01-19 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 40,800 20.32 829,056
2012-01-19 Goldstein Joseph L (Director) Sale 10,000 80.00 800,000
2012-01-12 Ryan Arthur F (Director) Sale 25,500 78.97 2,013,862
2012-01-11 Terifay Robert J (SVP Commercial) Sale 9,019 74.20 669,209
2012-01-11 Roberts William (VP Regulatory Development and) Sale 22,148 75.49 1,672,041
2012-01-10 Terifay Robert J (SVP Commercial) Option Ex 20,000 21.63 432,600
2012-01-10 Roberts William (VP Regulatory Development and) Sale 9,528 74.35 708,406
2012-01-10 Roberts William (VP Regulatory Development and) Option Ex 60,000 21.12 1,267,200
2012-01-10 Goldstein Joseph L (Director) Sale 20,000 74.57 1,491,339
2012-01-10 Goldstein Joseph L (Director) Option Ex 20,000 21.07 421,460
2012-01-05 Yancopoulos George (EVP, CSO & Pres, REGN Res Labs) Sale 27,713 58.00 1,607,354
2011-12-20 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 2,500 11.64 29,100
2011-12-16 Schleifer Leonard S (President & CEO) Option Ex 250,000 28.01 7,002,500
2011-12-01 Yancopoulos George (EVP CSO President Regeneron Re) Sale 27,713 59.16 1,639,362
2011-11-30 Yancopoulos George (EVP CSO President Regeneron Re) Option Ex 200,000 28.01 5,602,000
2011-11-22 Sing George L (Director) Option Ex 15,000 28.81 432,150
2011-11-14 Stahl Neil (SVP Research and Development S) Option Ex 17,182 11.64 199,998
2011-10-14 Goldstein Joseph L (Director) Sale 10,000 65.00 650,000
2011-10-14 Goldstein Joseph L (Director) Option Ex 10,000 23.84 238,400
2011-10-11 Terifay Robert J (SVP Commercial) Sale 7,214 65.16 470,064
2011-10-10 Terifay Robert J (SVP Commercial) Option Ex 29,372 21.34 626,798
2011-10-04 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 13,749 11.38 156,422
2011-09-21 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 4,200 67.00 281,400
2011-09-21 Brown Michael S (Director) Sale 5,000 78.00 390,000
2011-09-21 Brown Michael S (Director) Option Ex 5,000 9.17 45,850
2011-09-14 Ryan Arthur F (Director) Option Ex 115,000 18.44 2,120,370
2011-09-09 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 7,542 68.24 514,666
2011-09-08 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 26,000 11.64 302,640
2011-09-08 Brown Michael S (Director) Sale 5,000 74.00 370,000
2011-09-08 Brown Michael S (Director) Option Ex 5,000 9.17 45,850
2011-09-07 Aberman Michael S (VP Strategy and Investor Relat) Sale 3,377 69.04 233,137
2011-09-07 Stahl Neil (SVP Research and Development S) Sale 33,760 69.06 2,331,296
2011-09-07 Roberts William (VP Regulatory Development and) Sale 6,503 69.06 449,129
2011-09-07 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 13,531 69.06 934,518
2011-09-07 Brown Michael S (Director) Sale 5,000 69.00 345,000
2011-09-07 Brown Michael S (Director) Option Ex 5,000 9.17 45,850
2011-09-06 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 8,334 24.00 200,016
2011-09-06 Stahl Neil (SVP Research and Development S) Option Ex 82,818 11.64 964,001
2011-09-06 Roberts William (VP Regulatory Development and) Sale 16,463 65.54 1,078,985
2011-09-06 Roberts William (VP Regulatory Development and) Option Ex 30,000 11.64 349,200
2011-09-06 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 32,879 15.54 510,775
2011-09-06 Schleifer Leonard S (CEO & President) Sale 7,900 66.10 522,213
2011-09-02 Aberman Michael S (VP Strategy and Investor Relat) Sale 4,166 64.00 266,624
2011-09-02 Aberman Michael S (VP Strategy and Investor Relat) Option Ex 4,166 24.00 99,984
2011-09-02 Vagelos P Roy (Chairman of the Board) Sale 88,955 61.27 5,450,272
2011-09-01 Vagelos P Roy (Chairman of the Board) Sale 3,500 60.00 210,000
2011-08-31 Vagelos P Roy (Chairman of the Board) Option Ex 312,500 28.01 8,753,125
2011-08-16 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 6,409 56.86 364,415
2011-08-15 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 15,000 11.64 174,600
2011-08-10 Baker Charles A (Director) Option Ex 4,000 28.81 115,240
2011-08-04 Van Plew Daniel P (SVP & General Mgr Industrial O) Option Ex 4,784 20.90 99,985
2011-07-28 Goldberg Murray A (SVP Finance and Admin CFO Trea) Sale 9,705 54.48 528,689
2011-07-27 Goldberg Murray A (SVP Finance and Admin CFO Trea) Option Ex 21,963 9.49 208,428
2011-07-26 Powchik Peter (SVP Clinical Development) Sale 10,977 54.97 603,350
2011-07-25 Powchik Peter (SVP Clinical Development) Option Ex 25,000 15.64 391,000
2011-07-14 Roberts William (VP Regulatory Development and) Sale 110 56.75 6,242
2011-07-14 Vagelos P Roy (Chairman of the Board) Sale 658 56.75 37,341
2011-07-13 Roberts William (VP Regulatory Development and) Sale 4,322 57.09 246,742
2011-07-13 Vagelos P Roy (Chairman of the Board) Sale 25,935 57.09 1,480,629
2011-07-12 Roberts William (VP Regulatory Development and) Sale 3,939 57.11 224,956
2011-07-12 Vagelos P Roy (Chairman of the Board) Sale 23,635 57.12 1,350,031
2011-07-11 Roberts William (VP Regulatory Development and) Sale 4,129 58.30 240,733
2011-07-11 Vagelos P Roy (Chairman of the Board) Sale 24,772 58.30 1,444,281
2011-07-01 Goldstein Joseph L (Director) Sale 10,000 56.16 561,550
2011-07-01 Goldstein Joseph L (Director) Option Ex 10,000 28.81 288,100
2011-07-01 Baker Charles A (Director) Sale 11,000 56.63 622,963
2011-07-01 Baker Charles A (Director) Option Ex 11,000 28.81 316,910
2011-07-01 Brown Michael S (Director) Sale 25,000 56.19 1,404,825
2011-07-01 Brown Michael S (Director) Option Ex 25,000 24.47 611,825
2011-05-04 Goldstein Joseph L (Director) Sale 5,000 48.89 244,450
2011-05-04 Goldstein Joseph L (Director) Option Ex 5,000 28.81 144,050
2011-05-02 Gilman Alfred G (Director) Sale 20,000 50.90 1,017,900
2011-04-18 Brown Michael S (Director) Sale 5,000 49.00 245,000
2011-04-05 Stahl Neil (SVP Res and Dev Sciences) Sale 34,115 46.03 1,570,313

Insider trading activities including stock purchases, stock sales, and option exercises of REGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Regeneron Pharmaceuticals Inc (symbol REGN, CIK number 872589) see the Securities and Exchange Commission (SEC) website.